Phage lytic proteins are a clinically advanced class of novel enzyme-based antibiotics, so-called enzybiotics. A growing community of researchers develops phage lytic proteins with the perspective of their use as enzybiotics. A successful translation of enzybiotics to the market requires well-considered selections of phage lytic proteins in early research stages. Here, we introduce PhaLP, a database of phage lytic proteins, which serves as an open portal to facilitate the development of phage lytic proteins. PhaLP is a comprehensive, easily accessible and automatically updated database (currently 16,095 entries). Capitalizing on the rich content of PhaLP, we have mapped the high diversity of natural phage lytic proteins and conducted analyses at three levels to gain insight in their host-specific evolution. First, we provide an overview of the modular diversity. Secondly, datamining and interpretable machine learning approaches were adopted to reveal host-specific design rules for domain architectures in endolysins. Lastly, the evolution of phage lytic proteins on the protein sequence level was explored, revealing host-specific clusters. In sum, PhaLP can act as a starting point for the broad community of enzybiotic researchers, while the steadily improving evolutionary insights will serve as a natural inspiration for protein engineers.
The rising antimicrobial resistance is particularly alarming for Acinetobacter baumannii, calling for the discovery and evaluation of alternatives to treat A. baumannii infections. Some bacteriophages produce a structural protein that depolymerizes capsular exopolysaccharide. Such purified depolymerases are considered as novel antivirulence compounds. We identified and characterized a depolymerase (DpoMK34) from Acinetobacter phage vB_AbaP_PMK34 active against the clinical isolate A. baumannii MK34. In silico analysis reveals a modular protein displaying a conserved N-terminal domain for anchoring to the phage tail, and variable central and C-terminal domains for enzymatic activity and specificity. AlphaFold-Multimer predicts a trimeric protein adopting an elongated structure due to a long α-helix, an enzymatic β-helix domain and a hypervariable 4 amino acid hotspot in the most ultimate loop of the C-terminal domain. In contrast to the tail fiber of phage T3, this hypervariable hotspot appears unrelated with the primary receptor. The functional characterization of DpoMK34 revealed a mesophilic enzyme active up to 50 °C across a wide pH range (4 to 11) and specific for the capsule of A. baumannii MK34. Enzymatic degradation of the A. baumannii MK34 capsule causes a significant drop in phage adsorption from 95% to 9% after 5 min. Although lacking intrinsic antibacterial activity, DpoMK34 renders A. baumannii MK34 fully susceptible to serum killing in a serum concentration dependent manner. Unlike phage PMK34, DpoMK34 does not easily select for resistant mutants either against PMK34 or itself. In sum, DpoMK34 is a potential antivirulence compound that can be included in a depolymerase cocktail to control difficult to treat A. baumannii infections.
As biology grows increasingly data-driven, so too does the field of phage lysins, enzymes that degrade bacterial cell walls and hold promise as alternatives to traditional antibiotics. Five years ago, we introduced PhaLP, a centralized resource for Pha ge L ytic P rotein sequences and associated metadata to support global research efforts. Here, we present PhaLP 2.0, a significantly enhanced database designed to overcome key challenges in the computational study of lysins by integrating the newly identified lysins obtained from thousands of metagenomes. To expand the known diversity of lysins beyond those from cultured phages, we developed SUBLYME, a protein embedding-based machine learning S oftware designed to U ncover and classify B acteriophage Ly sins in Me tagenomic datasets. Using embeddings derived from the prior well-curated protein sequences of the original PhaLP database, we trained support vector machines to distinguish lysins from non-lysins in viromes and classify them as either endolysins or virion-associated lysins. The models achieved an average F1-score of 98% on held-out lysin clusters. SUBLYME enabled the discovery of 743,000 new lysin sequences from EnVhogDB, a virome-derived protein database, increasing the number of known lysin clusters by a factor of 40, from 1,000 to 40,000. PhaLP 2.0 entries were annotated by integrating Pfam functional predictions to the refined delineations obtained with SPAED, an algorithm that leverages the predicted aligned error matrix from AlphaFold predictions to identify domain boundaries. Both SUBLYME and the PhaLP 2.0 database are accessible online at https://github.com/Rousseau-Team/sublyme and http://phalp.ugent.be, respectively. Together, these advances establish PhaLP 2.0 as a comprehensive and scalable portal for the discovery, classification, and sequence analysis of phage lysins, paving the way for future antibacterial applications and evolutionary insights.